Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Shares Outstanding (Diluted Average) (2018 - 2026)

Bioceres Crop Solutions' Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $63.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.27% to $63.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $63.6 million, a 1.27% increase, with the full-year FY2022 number at $182.4 million, up 5.89% from a year prior.
  • Shares Outstanding (Diluted Average) hit $63.6 million in Q1 2026 for Bioceres Crop Solutions, up from $62.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for BIOX hit a ceiling of $182.4 million in Q2 2022 and a floor of $62.8 million in Q1 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $102.9 million across 3 years, with a median of $63.6 million in 2026.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 5.89% in 2022 and later increased 1.27% in 2026.
  • Tracing BIOX's Shares Outstanding (Diluted Average) over 3 years: stood at $182.4 million in 2022, then crashed by 65.56% to $62.8 million in 2025, then increased by 1.27% to $63.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for BIOX at $63.6 million in Q1 2026, $62.8 million in Q1 2025, and $182.4 million in Q2 2022.